Clinical Trial Update: Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial from the University of Southampton is exploring ctDNA-guided adjuvant therapy for gastroesophageal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Cancer

Snippet

Sponsor: University of Southampton | Conditions: Gastrooesophageal Cancer | Phase 2 | Status: RECRUITING